Villere St Denis J & CO LLC Amgen Inc Transaction History

Villere St Denis J & CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $183,370 - $214,951	-1,100 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $92,645 - $104,445	-500 Reduced 31.25%	1,100 $228,000
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $267,664 - $305,600	1,600	1,600 $298,000

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Villere St Denis J & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Villere St Denis J & CO LLC with notifications on news.